Director
Ian de Boer, M.D., M.S.
Director of KRI, University of Washington Professor of Medicine, Holder of the Joseph W. Eschbach Endowed Chair in Kidney Research; Professor of Medicine, Nephrology; Adjunct Professor, Epidemiology
Kidney Research Institute
University of Washington
Box 359606
325 9th ave
Seattle, WA 98104
Education and Training
Medical School
Oregon Health Sciences University
School of Medicine
Medical Residency
University of California
San Francisco, CA
Nephrology Fellowship
University of Washington
Seattle, WA
Masters of Science, Epidemiology
University of Washington
Seattle, WA
Research Interests
Prevention and early identification of chronic kidney disease
Diabetic kidney disease
Vitamin D deficiency and kidney disease
SELECTED PUBLICATIONS
Glenda V. Roberts
DIRECTOR OF EXTERNAL RELATIONS AND PATIENT ENGAGEMENT, KIDNEY RESEARCH INSTITUTE;
DIRECTOR OF EXTERNAL RELATIONS AND PATIENT ENGAGEMENT, CENTER FOR DIALYSIS INNOVATION;
CHIEF STRATEGY AND OPERATIONS OFFICER;
UW JUSTICE, EQUITY, DIVERSITY, AND INCLUSION CENTER FOR TRANSFORMATIVE RESEARCH
Kidney Research Institute
University of Washington
Box 359606
325 9th Ave
Seattle, WA 98104
Education and Training
Bachelor of Science, Mathematics
University of Houston
Houston, TX
Research Interests
Patient engagement in kidney research
Patient Advisory Committees/Boards in kidney research
Health equity and diversity
SELECTED PUBLICATIONS
Jonathan Himmelfarb, M.D.
Inaugural Director of KRI, University of Washington Professor of Medicine
Kidney Research Institute
University of Washington
Box 359606
325 9th Ave
Seattle, WA 98104
Education and Training
Medical School
George Washington University
Washington, DC
Medical Residency
Maine Medical Center
Portland, ME
Nephrology Fellowship
Maine Medical Center
Portland, ME
Nephrology Fellowship
Brigham & Women's Hospital
Boston, MA
Research Interests
1. Epidemiology of acute kidney injury and chronic kidney disease, with a focus on public health
2. Metabolic complications associated with kidney disease, including oxidative stress, inflammation and insulin resistance
3. Uremic toxicity
4. Altered drug metabolism, and mechanisms of drug induced nephrotoxicity in kidney disease.
5. Biomarker discovery and evaluation in kidney disease
6. Clinical trials in ESRD, CKD, and AKI